| Antibiotic prescribing without documented indication in ambulatory care clinics: national cross sectional study MJ Ray, GB Tallman, DT Bearden, MR Elman, JC McGregor bmj 367, 2019 | 75 | 2019 |
| Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic … M Hakki, RM Humphries, P Hemarajata, GB Tallman, RK Shields, ... Clinical Infectious Diseases 68 (12), 2045-2052, 2019 | 50 | 2019 |
| Potential for Pharmacy–Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases PO Gubbins, ME Klepser, AJ Adams, DM Jacobs, KM Percival, ... Journal of Public Health Management and Practice 23 (6), 593-600, 2017 | 37 | 2017 |
| Remdesivir and Mortality in Patients With Coronavirus Disease 2019 GA Diaz, AB Christensen, T Pusch, D Goulet, SC Chang, GL Grunkemeier, ... Clinical Infectious Diseases 74 (10), 1812-1820, 2022 | 35 | 2022 |
| Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre CD Bowen, GB Tallman, M Hakki, JS Lewis Ⅱ Mycoses 62 (8), 665-672, 2019 | 30 | 2019 |
| Empiric Antibiotic Prescribing Decisions Among Medical Residents: The Role of the Antibiogram GB Tallman, RA Vilches-Tran, MR Elman, DT Bearden, JE Taylor, ... Infection Control & Hospital Epidemiology 39 (5), 578-583, 2018 | 20 | 2018 |
| Clinical outcomes of oral suspension versus delayed-release tablet formulations of posaconazole for prophylaxis of invasive fungal infections JP Furuno, GB Tallman, BN Noble, JS Bubalo, GN Forrest, JS Lewis, ... Antimicrobial agents and chemotherapy 62 (10), e00893-18, 2018 | 19 | 2018 |
| General Perceptions and Knowledge of Antibiotic Resistance and Antibiotic Use Behavior: A Cross-Sectional Survey of US Adults CM McCracken, KJ Tucker, GB Tallman, HK Holmer, BN Noble, ... Antibiotics 12 (4), 672, 2023 | 7 | 2023 |
| Impact of a Laboratory-Developed Phenotypic Rapid Susceptibility Test Directly From Positive Blood Cultures on Time to Narrowest Effective Therapy in Patients With Gram … AB Christensen, B Footer, T Pusch, K Heath, M Iqbal, L Wang, G Tallman, ... Open forum infectious diseases 9 (7), ofac347, 2022 | 5 | 2022 |
| 2058. Patient Satisfaction Not Impacted by Antibiotic Prescribing for Viral Upper Respiratory Infections. MJ Ray, GB Tallman, CM McCracken, MR Elman, JC McGregor Open Forum Infectious Diseases 6, 2019 | 2 | 2019 |
| 1502. Identifying Risk Factors for Recurrent Urinary Tract Infections Among Female Outpatients B Morgan, GB Tallman, MR Elman, DT Bearden, JC McGregor Open Forum Infectious Diseases 5 (Suppl 1), S464, 2018 | 2 | 2018 |
| 1027. Vancomycin Use in Community-Acquired Pneumonia: Assessing Inappropriate Therapy. T Shan, SJ Gore, CM McCracken, GB Tallman, HK Holmer, DT Bearden, ... Open Forum Infectious Diseases 6, 2019 | 1 | 2019 |
| Comment: Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting O Samaan, D Bojorquez, GB Tallman Annals of Pharmacotherapy, 0 | 1* | |
| A Quasi-Experimental Study of Trough-Guided versus Area under the Curve-Guided Vancomycin Monitoring in Patients with Methicillin Resistant Staphylococcus aureus Bacteremia … J Donat, B Footer, GB Tallman | | 2023 |
| 1828. Dalbavancin Utilization and Associated Clinical Outcomes: A Case-Series MN Greckel, B Footer, A Christensen, A Christensen, GB Tallman, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1458, 2022 | | 2022 |
| 1091. Validation of an Allometrically Scaled Body Weight Equation to Predict Vancomycin Clearance and Guide 24-Hour Vancomycin AUC Dosing in Obese Patients B Footer, A Nguyen, M Greckel, C Taylor, A Christensen, G Tallman Open Forum Infectious Diseases 8 (Supplement_1), S636-S637, 2021 | | 2021 |
| 1034. Automating Assessments of Vancomycin Appropriateness HK Holmer, CM McCracken, GB Tallman, SJ Gore, T Shan, D Yu, ... Open Forum Infectious Diseases 6 (Suppl 2), S364, 2019 | | 2019 |
| Next Steps in Predicting Anti-MRSA Antibiotic Prescribing: 1873. H Holmer, A Pakyz, G Tallman, M Elman, S Hohmann, R Fu, K Kuper, ... Open Forum Infectious Diseases 5, 2018 | | 2018 |
| 1873. Next Steps in Predicting Anti-MRSA Antibiotic Prescribing HK Holmer, A Pakyz, GB Tallman, MR Elman, S Hohmann, R Fu, K Kuper, ... Open Forum Infectious Diseases 5 (Suppl 1), S535, 2018 | | 2018 |
| Clinical Outcomes of the Oral Suspension vs Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections GB Tallman, JP Furuno, BN Noble, JS Bubalo, GN Forrest, JS Lewis, ... Open Forum Infectious Diseases 4 (suppl_1), S86-S86, 2017 | | 2017 |
David BeardenOregon State University / Oregon Health & Science UniversityVerified email at ohsu.edu
